Fundraising FoxChad May
CSO at Orum Therapeutics Venture Capital
San Carlos, California, United States
Find your path to Chad
Sign up to see every warm intro you have to Chad
- Paths you didn't know you had: your email and LinkedIn already hold routes to Chad. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Chad May is Chief Scientific Officer at Orum Therapeutics, where he leads scientific research and development and preclinical oncology research from target validation and candidate selection through IND submission and Phase 1 clinical trials. His work covers therapeutic modalities including monoclonal antibodies, antibody drug conjugates, radioconjugates, T cell engagers, and CAR-T cell therapies, along with portfolio strategy, business development, and investor relations.
Frequently asked questions
- Who is Chad May?
- Chad May is Chief Scientific Officer at Orum Therapeutics, where he leads scientific research and development and preclinical oncology research from target validation and candidate selection through IND submission and Phase 1 clinical trials. His work covers therapeutic modalities including monoclonal antibodies, antibody drug conjugates, radioconjugates, T cell engagers, and CAR-T cell therapies, along with portfolio strategy, business development, and investor relations.
About this profile. Compiled from public sources — the organisations' own websites and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights